Details for Patent: 8,173,814
✉ Email this page to a colleague
Title: | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quin- olinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
Abstract: | The present invention relates to maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quin- olinyl}-4-(dimethylamino)-2-butenamide, methods of preparing crystalline maleate salt forms, the associated compounds, and pharmaceutical compositions containing the same. The maleate salts are useful in treating cancers, particularly those affected by kinases of the epidermal growth factor receptor family. |
Inventor(s): | Lu; Qinghong (Suffern, NY), Ku; Mannching Sherry (Thiells, NY), Chew; Warren (Pierrefonds, CA), Cheal; Gloria (Beaconsfield, CA), Hadfield; Anthony F. (St. Petersburg, FL), Mirmehrabi; Mahmoud (Laval, CA) |
Assignee: | Wyeth LLC (Madison, NJ) |
Filing Date: | Jul 12, 2011 |
Application Number: | 13/181,375 |
Claims: | 1. An isolated crystalline form of anhydrous (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quin- olinyl}-4-(dimethylamino)-2-butenamide maleate, characterized by X-ray diffraction peaks at the following angles (.+-.0.20.degree.) of 2.theta. in its X-ray diffraction pattern: 6.16, 7.38, 8.75, 10.20, 12.24, 12.61, 14.65, 15.75, 17.33, 18.64, 19.99, 20.66, 21.32, 22.30, 23.18, 24.10, 24.69, 25.49, 26.09, 26.54, 27.52, 28.62, and 29.43. 2. An isolated crystalline form according to claim 1 having substantially the X-ray diffraction pattern as shown in FIG. 6. 3. An isolated crystalline form of anhydrous (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quin- olinyl}-4-(dimethylamino)-2-butenamide maleate, characterized by X-ray diffraction peaks at the following angles (.+-.0.20.degree.) of 2.theta. in its X-ray diffraction pattern: 6.16, 7.38, 8.75, 12.61, 14.65, 15.75. 4. An isolated crystalline form according to claim 3 having substantially the X-ray diffraction pattern as shown in FIG. 6. |